Advanced

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.

Johnell, Olof LU ; Scheele, Wim H; Lu, Yili; Reginster, Jean-Yves; Need, Allan G and Seeman, Ego (2002) In Journal of Clinical Endocrinology and Metabolism 87(3). p.92-985
Please use this url to cite or link to this publication:
@article{667a8443-1e3c-4175-9a28-6d8db4fef2f0,
  author       = {Johnell, Olof and Scheele, Wim H and Lu, Yili and Reginster, Jean-Yves and Need, Allan G and Seeman, Ego},
  issn         = {1945-7197},
  keyword      = {Non-U.S. Gov't,Osteoporosis,Bone Density: drug effects,Biological Markers: blood,Alendronate: therapeutic use,Aged,Bone Remodeling: drug effects,Lumbar Vertebrae: drug effects,Human,Femur Neck: physiopathology,Femur Neck: drug effects,Female,Drug Synergism,Double-Blind Method,Collagen: antagonists & inhibitors,Bone Remodeling: physiology,Lumbar Vertebrae: physiopathology,Osteocalcin: antagonists & inhibitors,Middle Age,Postmenopausal: drug therapy,Postmenopausal: physiopathology,Peptides: antagonists & inhibitors,Raloxifene: therapeutic use,Selective Estrogen Receptor Modulators: therapeutic use,Support},
  language     = {eng},
  number       = {3},
  pages        = {92--985},
  publisher    = {The Endocrine Society},
  series       = {Journal of Clinical Endocrinology and Metabolism},
  title        = {Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.},
  volume       = {87},
  year         = {2002},
}